Correspondence on: 'EULAR definition of difficult-to-treat rheumatoid arthritis'
Ann Rheum Dis
.
2023 Mar;82(3):e55.
doi: 10.1136/annrheumdis-2020-219500.
Epub 2020 Dec 4.
Authors
Marta Novella-Navarro
1
,
Chamaida Plasencia-Rodríguez
2
,
Carolina Tornero
2
,
Victoria Navarro-Compán
2
,
José Luis Cabrera-Alarcón
3
,
Diana Peiteado
2
,
Laura Nuño
2
,
Irene Monjo
2
,
Karen Franco-Gómez
2
,
Alejandro Villalba
2
,
Alejandro Balsa
2
Affiliations
1
Rheumatology, La Paz University Hospital, Madrid, Spain mnovellanavarro@gmail.com.
2
Rheumatology, La Paz University Hospital, Madrid, Spain.
3
Bioinformatic Unit (GENOXPHOS Group), Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
PMID:
33277240
DOI:
10.1136/annrheumdis-2020-219500
No abstract available
Keywords:
arthritis; biological therapy; rheumatoid; therapeutics.
Publication types
Letter
Comment
MeSH terms
Antirheumatic Agents* / therapeutic use
Arthritis, Rheumatoid* / drug therapy
Humans
Substances
Antirheumatic Agents